Stay updated on Adjuvant Nivolumab for Stage II Melanoma Clinical Trial

Sign up to get notified when there's something new on the Adjuvant Nivolumab for Stage II Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adjuvant Nivolumab for Stage II Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page footer was updated to reflect a new ClinicalTrials.gov revision number (from v3.5.2 to v3.5.3). This represents an interface/version update rather than a change to the trial record history itself.
    Difference
    0.1%
    Check dated 2026-04-24T05:41:44.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:12:39.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 to the Record History and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T22:18:54.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 from the history.
    Difference
    0.1%
    Check dated 2026-03-11T17:21:47.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the history, and the government funding lapse notice along with Revision: v3.4.1 were removed from the visible history.
    Difference
    0.7%
    Check dated 2026-02-11T10:31:08.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Adds a site-wide notice about a lapse in government funding and introduces revision tag v3.4.1 (replacing v3.4.0) on the history page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-04T05:58:21.000Z thumbnail image

Stay in the know with updates to Adjuvant Nivolumab for Stage II Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adjuvant Nivolumab for Stage II Melanoma Clinical Trial page.